Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Differentiation | 7 | 2017 | 64 | 1.820 |
Why?
|
| Adipose Tissue, Brown | 4 | 2017 | 11 | 1.470 |
Why?
|
| Follistatin | 4 | 2017 | 15 | 1.360 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 144 | 1.220 |
Why?
|
| Mice | 10 | 2020 | 555 | 0.690 |
Why?
|
| Testosterone | 4 | 2011 | 43 | 0.690 |
Why?
|
| Animals | 11 | 2020 | 1369 | 0.670 |
Why?
|
| Adipocytes | 2 | 2014 | 22 | 0.640 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 2 | 0.550 |
Why?
|
| Adipocytes, White | 1 | 2017 | 2 | 0.550 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 3 | 0.550 |
Why?
|
| Energy Metabolism | 2 | 2014 | 19 | 0.540 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 34 | 0.530 |
Why?
|
| Muscle, Skeletal | 5 | 2013 | 64 | 0.500 |
Why?
|
| Up-Regulation | 6 | 2020 | 70 | 0.480 |
Why?
|
| Biomarkers | 1 | 2015 | 160 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 2 | 2011 | 45 | 0.440 |
Why?
|
| Myostatin | 2 | 2013 | 22 | 0.440 |
Why?
|
| Nitric Oxide | 2 | 2013 | 44 | 0.420 |
Why?
|
| Down-Regulation | 2 | 2013 | 43 | 0.420 |
Why?
|
| Female | 7 | 2020 | 2964 | 0.410 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 3 | 0.410 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 3 | 0.410 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 13 | 0.410 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 14 | 0.410 |
Why?
|
| Cell Proliferation | 2 | 2020 | 101 | 0.390 |
Why?
|
| Vitamin D | 1 | 2013 | 35 | 0.390 |
Why?
|
| Muscle Development | 2 | 2011 | 12 | 0.390 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 3 | 0.380 |
Why?
|
| Receptors, Androgen | 3 | 2011 | 19 | 0.360 |
Why?
|
| Signal Transduction | 4 | 2017 | 162 | 0.330 |
Why?
|
| Cells, Cultured | 3 | 2017 | 164 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 196 | 0.320 |
Why?
|
| Male | 6 | 2017 | 2620 | 0.290 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 4 | 0.270 |
Why?
|
| Neoplastic Stem Cells | 3 | 2020 | 19 | 0.270 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 104 | 0.260 |
Why?
|
| Thermogenesis | 2 | 2017 | 5 | 0.250 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 12 | 0.250 |
Why?
|
| Uncoupling Protein 1 | 2 | 2015 | 6 | 0.230 |
Why?
|
| Ion Channels | 2 | 2015 | 8 | 0.230 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 8 | 0.230 |
Why?
|
| Lipid Metabolism | 2 | 2014 | 28 | 0.210 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 4 | 0.210 |
Why?
|
| Androgens | 1 | 2003 | 19 | 0.210 |
Why?
|
| Mice, Knockout | 2 | 2014 | 112 | 0.210 |
Why?
|
| Transcription Factors | 2 | 2013 | 32 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2014 | 20 | 0.180 |
Why?
|
| Humans | 6 | 2020 | 4931 | 0.180 |
Why?
|
| Animal Feed | 1 | 2020 | 10 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 21 | 0.170 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 46 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 14 | 0.170 |
Why?
|
| Nicotine | 1 | 2020 | 91 | 0.160 |
Why?
|
| Body Composition | 2 | 2013 | 45 | 0.160 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 4 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 83 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 42 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2015 | 8 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2015 | 11 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2020 | 92 | 0.120 |
Why?
|
| Smad Proteins | 2 | 2011 | 9 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2011 | 55 | 0.110 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cold Temperature | 1 | 2014 | 2 | 0.110 |
Why?
|
| Proton Ionophores | 1 | 2014 | 2 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2014 | 10 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 9 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 22 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 72 | 0.110 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 2 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 5 | 0.110 |
Why?
|
| Genotype | 1 | 2013 | 18 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 26 | 0.110 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 3 | 0.100 |
Why?
|
| Retinoid X Receptors | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 5 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 9 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2013 | 34 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 28 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 62 | 0.100 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 2 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 6 | 0.090 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 6 | 0.090 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 10 | 0.090 |
Why?
|
| Gene Expression | 1 | 2011 | 55 | 0.090 |
Why?
|
| Obesity | 1 | 2013 | 189 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 34 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 137 | 0.080 |
Why?
|
| Myoblasts | 1 | 2008 | 6 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 8 | 0.070 |
Why?
|
| Mesoderm | 1 | 2008 | 9 | 0.070 |
Why?
|
| Cell Line | 2 | 2008 | 82 | 0.070 |
Why?
|
| Androstenedione | 1 | 2004 | 4 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 10 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 10 | 0.050 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 2 | 0.050 |
Why?
|
| Anilides | 1 | 2003 | 4 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 3 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 35 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 35 | 0.050 |
Why?
|
| Nitriles | 1 | 2003 | 11 | 0.050 |
Why?
|
| Mecamylamine | 1 | 2020 | 6 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 7 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2020 | 8 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 17 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 21 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 122 | 0.040 |
Why?
|
| Adult | 2 | 2004 | 1402 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 21 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 36 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 36 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 62 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 127 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 245 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 12 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 43 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 13 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 41 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 10 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2003 | 12 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 14 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 66 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 98 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 177 | 0.010 |
Why?
|
| Child | 1 | 2003 | 336 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 569 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 1544 | 0.010 |
Why?
|